207 related articles for article (PubMed ID: 23066091)
21. Functional interactions between the oxytocin receptor and the β2-adrenergic receptor: implications for ERK1/2 activation in human myometrial cells.
Wrzal PK; Goupil E; Laporte SA; Hébert TE; Zingg HH
Cell Signal; 2012 Jan; 24(1):333-41. PubMed ID: 21964067
[TBL] [Abstract][Full Text] [Related]
22. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
23. beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase.
Colombo F; Noël J; Mayers P; Mercier I; Calderone A
J Mol Cell Cardiol; 2001 Jun; 33(6):1091-106. PubMed ID: 11444915
[TBL] [Abstract][Full Text] [Related]
24. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
[TBL] [Abstract][Full Text] [Related]
25. Differential changes in beta-adrenoceptor signal transduction in left and right ventricles of infarcted rats.
Sethi R; Saini HK; Wang X; Elimban V; Babick A; Dhalla NS
Can J Physiol Pharmacol; 2006 Jul; 84(7):747-54. PubMed ID: 16998538
[TBL] [Abstract][Full Text] [Related]
26. Diverse regulation of cardiac expression of relaxin receptor by α1- and β1-adrenoceptors.
Moore XL; Su Y; Fan Y; Zhang YY; Woodcock EA; Dart AM; Du XJ
Cardiovasc Drugs Ther; 2014 Jun; 28(3):221-8. PubMed ID: 24852484
[TBL] [Abstract][Full Text] [Related]
27. Role of AKAP79/150 protein in β1-adrenergic receptor trafficking and signaling in mammalian cells.
Li X; Nooh MM; Bahouth SW
J Biol Chem; 2013 Nov; 288(47):33797-33812. PubMed ID: 24121510
[TBL] [Abstract][Full Text] [Related]
28. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice.
Devic E; Xiang Y; Gould D; Kobilka B
Mol Pharmacol; 2001 Sep; 60(3):577-83. PubMed ID: 11502890
[TBL] [Abstract][Full Text] [Related]
29. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
Nikolaev VO; Bünemann M; Schmitteckert E; Lohse MJ; Engelhardt S
Circ Res; 2006 Nov; 99(10):1084-91. PubMed ID: 17038640
[TBL] [Abstract][Full Text] [Related]
30. Regulation of pendrin by cAMP: possible involvement in β-adrenergic-dependent NaCl retention.
Azroyan A; Morla L; Crambert G; Laghmani K; Ramakrishnan S; Edwards A; Doucet A
Am J Physiol Renal Physiol; 2012 May; 302(9):F1180-7. PubMed ID: 22262479
[TBL] [Abstract][Full Text] [Related]
31. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
[TBL] [Abstract][Full Text] [Related]
32. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
Hillman KL; Doze VA; Porter JE
J Pharmacol Exp Ther; 2005 Aug; 314(2):561-7. PubMed ID: 15908513
[TBL] [Abstract][Full Text] [Related]
33. Beta-adrenergic receptor-mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a phosphatidylinositol 3-kinase dependent pathway refractory to the antiproliferative action of cyclic AMP.
Colombo F; Gosselin H; El-Helou V; Calderone A
J Cell Physiol; 2003 May; 195(2):322-30. PubMed ID: 12652658
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
35. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
Nisoli E; Tonello C; Landi M; Carruba MO
Mol Pharmacol; 1996 Jan; 49(1):7-14. PubMed ID: 8569714
[TBL] [Abstract][Full Text] [Related]
36. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support.
Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H
J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
Nasrollahi-Shirazi S; Sucic S; Yang Q; Freissmuth M; Nanoff C
J Pharmacol Exp Ther; 2016 Oct; 359(1):73-81. PubMed ID: 27451411
[TBL] [Abstract][Full Text] [Related]
38. beta2- but not beta1-adrenoceptor activation modulates intracellular oxygen availability.
Li J; Yan B; Huo Z; Liu Y; Xu J; Sun Y; Liu Y; Liang D; Peng L; Zhang Y; Zhou ZN; Shi J; Cui J; Chen YH
J Physiol; 2010 Aug; 588(Pt 16):2987-98. PubMed ID: 20547682
[TBL] [Abstract][Full Text] [Related]
39. Expression and functions of β1- and β2-adrenergic receptors on the bulbospinal neurons in the rostral ventrolateral medulla.
Oshima N; Onimaru H; Yamamoto K; Takechi H; Nishida Y; Oda T; Kumagai H
Hypertens Res; 2014 Nov; 37(11):976-83. PubMed ID: 24965172
[TBL] [Abstract][Full Text] [Related]
40. Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Jun; 63(6):1312-21. PubMed ID: 12761341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
